|
⚲
|
| Keyboard |
| Junius Daniel M
✚
|
|
|---|---|
| CIK # | 0001094159 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001094159] | |
| 4 | [0001094159] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Junius Daniel M | |
| Idexx Laboratories Inc /DE | |
| Crescent Biopharma Inc | |
| ImmunoGen Inc | |
| Vitae Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Idexx Laboratories Inc /DE IDXX
Common Stock
|
2025-05-13 | Option exercise | 1,279 | $283.59 | 362,712 |
|
Idexx Laboratories Inc /DE IDXX
Common Stock
|
2025-05-13 | Option exercise | 1,404 | $245.79 | 345,089 |
|
Idexx Laboratories Inc /DE IDXX
Common Stock
|
2025-05-13 | Sell | 2,683 | $506.41 | 1,358,698 |
|
Idexx Laboratories Inc /DE IDXX
Non-Qualified Stock Option (right-to-buy) · derivative
|
2025-05-13 | Option exercise | 1,279 | $0.00 | |
|
Idexx Laboratories Inc /DE IDXX
Non-Qualified Stock Option (right-to-buy) · derivative
|
2025-05-13 | Option exercise | 1,404 | $0.00 | |
|
Idexx Laboratories Inc /DE IDXX
Restricted Stock Unit · derivative
|
2025-05-07 | Grant | 257 | $0.00 | |
|
Idexx Laboratories Inc /DE IDXX
Non-Qualified Stock Option (right-to-buy) · derivative
|
2025-05-07 | Grant | 600 | $0.00 | |
|
Idexx Laboratories Inc /DE IDXX
Common Stock
|
2025-05-06 | Option exercise | 262 | $0.00 | |
|
Idexx Laboratories Inc /DE IDXX
Restricted Stock Unit · derivative
|
2025-05-06 | Option exercise | 262 | $0.00 | |
|
Idexx Laboratories Inc /DE IDXX
Non-Qualified Stock Option (right-to-buy) · derivative
|
2024-05-06 | Grant | 609 | $0.00 | |
|
Idexx Laboratories Inc /DE IDXX
Restricted Stock Unit · derivative
|
2024-05-06 | Grant | 262 | $0.00 | |
|
Crescent Biopharma Inc GLYC
Stock Option (right to buy) · derivative
|
2024-05-01 | Grant | 40,000 | $0.00 | |
|
Crescent Biopharma Inc GLYC
Common Stock
|
2024-03-29 | Grant | 5,209 | $3.00 | 15,627 |
|
Idexx Laboratories Inc /DE IDXX
Common Stock
|
2024-01-30 | Grant | 14 | $521.03 | 7,294 |
|
Idexx Laboratories Inc /DE IDXX
Common Stock
|
2023-10-30 | Grant | 19 | $396.39 | 7,531 |
|
Idexx Laboratories Inc /DE IDXX
Common Stock
|
2023-07-28 | Grant | 14 | $552.78 | 7,739 |
|
Crescent Biopharma Inc GLYC
Stock Option (right to buy) · derivative
|
2023-05-19 | Grant | 35,000 | $0.00 | |
|
Idexx Laboratories Inc /DE IDXX
Deferred Stock Unit · derivative
|
2023-05-17 | Grant | 257 | ||
|
Idexx Laboratories Inc /DE IDXX
Non-Qualified Stock Option (right-to-buy) · derivative
|
2023-05-17 | Grant | 645 | $0.00 | |
|
Crescent Biopharma Inc GLYC
Common Stock
|
2023-05-10 | Buy | 30,000 | $1.56 | 46,800 |
| showing 20 of 200 most recent transactions | |||||